Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator had banned the company’s e-cigarettes in 2022, but they stayed on store shelves while an appeal process played out.
The world’s largest fast food chain lost its “Big Mac” trademark for chicken sandwiches following a European Union court ruling.
The plaintiffs argue the league made an anti-competitive agreement forcing fans to pay for out-of-market broadcasts in one package.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Beijing is reportedly unhappy with the prospect of an EU tariff on EVs, and is considering retaliatory tariffs on the EU’s aviation industry.
The industry just boosted its profit forecast for 2024 but warns that return on invested capital hurts the chance for sustainable profits.
One market research firm said even duties in the range of 15%-30% won’t keep most of the country’s carmakers out of Europe.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The big services are working on a structure that will weigh factors such as viewership time, production budget, and new subscriptions added.
Once thought to be fizzling, fizzy drinks are bubbling with growth and investment at a pace not seen in years.
The FAA won’t clear the current production cap and plans to approve every single plane that comes off Boeing’s production lines.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.